Navigation Links
LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
Date:10/29/2013

AUSTIN, Texas, Oct. 29, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will host an investor event in Phoenix, Arizona at the Association for Molecular Pathology Annual Meeting on Wednesday, November 13, 2013 beginning at 5:30 pm Mountain time.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Patrick J. Balthrop, president and chief executive officer, and other members of the executive management team will provide insight into the company's long-term strategic plans, including a live demonstration of the Company's revolutionary sample-to-answer System, Project ARIES.

Advanced registration is required and attendance will be limited to those registered. To register, please contact Matthew Norman, Government and Investor Relations Manager.  Dinner will be served following the event.

The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

About Luminex Corporation
Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.

Contacts:

Matthew Norman, 512.219.8020
Government and Investor Relations Manager
mnorman@luminexcorp.com

Harriss Currie, 512.219.8020
Sr. Vice President and CFO
hcurrie@luminexcorp.com


'/>"/>
SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Reports First Quarter 2012 Results
2. Luminex Corporation Announces Agreement to Acquire GenturaDx
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
4. Luminex Corporation Reports Second Quarter 2012 Results
5. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
6. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
7. Luminex Corporation Recognized as Best Technology Company in Austin
8. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
9. Luminex Corporation To Present At Upcoming Investment Conferences In September
10. Luminex Corporation Reports Third Quarter 2012 Results
11. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... Pa. (PRWEB) , ... October 09, 2019 , ... “When ... the emotions, frustrations, and the realities of the HEMS world through telling the real ... Helicopter Pilot” is the creation of published author Jay A. Humphrey, an EMS helicopter ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... Dr. Ryan ... at the 2019 Academy of Integrative Health and Medicine conference. Their presentation titled Advances ... integrative treatments and how they can be used to promote brain health, and reduce ...
(Date:10/8/2019)... ... 08, 2019 , ... Dr. Eric Baker and Dr. Tim ... dental and medical training to offer medically compromised patients predictable and ... diabetes, and other systemic concerns for dental implants and other oral surgeries to ...
Breaking Medicine Technology:
(Date:10/17/2019)... Calif. (PRWEB) , ... October 17, 2019 , ... Knotty ... magnetic roller case, quickly broke its campaign goal– raising more than $20,000 in only ... response from the crowdfunding community, who’ll be the first to enjoy the ease of ...
(Date:10/15/2019)... , ... October 14, 2019 , ... Khalieghya Dandie-Evans, a ... to ride atop the Donate Life Rose Parade® float in the 131st Rose Parade® ... and tissue donation across Northern California and Northern Nevada, the organization’s service area. , ...
(Date:10/15/2019)... , ... October 15, 2019 , ... Genomenon® ... with SOPHiA GENETICS that includes incorporating the Mastermind® Genomic Search Engine ... the most up-to-date genomic research at the fingertips of clinical researchers performing genomic analysis ...
(Date:10/11/2019)... ... ... A Topping Out event was hosted today at the construction site of the Southwest ... event celebrated reaching the final height of the structure set to open in the ... in Texas, STA’s facility will be home to an organ recovery center including a ...
(Date:10/10/2019)... ... 10, 2019 , ... In attendance at this year’s ISSN ... the significant results of an independent study presented by researchers from the University ... poster entitled “The Acute Effects of Citrulline Malate and Bonded Arginine Silicate Supplementation ...
Breaking Medicine News(10 mins):